Objective-The goal of this study was to examine the functional relationship between aging endothelium and thrombogenicity in a mouse model of premature aging. 
T he incidence of cardiovascular thrombotic complications increases dramatically with age. 1 Advanced age leads to a state of hypercoagulability in the blood, raising the relative risk for deep vein thrombosis from Ϸ1/10,000 at the age of 40 to 1/100 at the age of 80. 2 Hypercoagulability in the blood of the elderly likely results from elevation of plasma coagulation factors VII (FVII), FVIII, and FXIII; plasma levels of plasminogen activator inhibitor 1, an inhibitor of fibrinolysis, also increase. 1 Procoagulant changes are not accompanied by a proportional parallel rise in plasma levels of natural anticoagulant factors, such as proteins C and S, ie, the hemostatic balance between pro-and anticoagulant pathways is shifted toward an elevated risk for deep vein thrombosis. 2 Shear stress-modulated von Willebrand factor (VWF), present in endothelial cells and subendothelium, is a potent platelet agonist, and elevated levels are a risk factor for atherothrombosis. 3 It increases with age, a phenomenon believed to primarily reflect endothelial dysfunction. There is, however, still controversy over whether platelet function is affected by aging. 1, 4 Although VWF and FVIII are independent risk factors for atherothrombotic disease, 3 the functional relationship between atherothrombosis and modifications in the aging endothelium is not fully understood. 5 
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Arterial aging is associated with increased collagen deposition, thickening of the intima-media of the human carotid artery (2-to 3-fold between 20 and 90 years of age), and reduced vascular elasticity and is accompanied by a reduction of endothelial cellular function, ie, endothelial cell-mediated vasodilation, the consequence of diminished release of nitric oxide (NO) by endothelial cells. The reduced NO bioavailability results from elevated production of reactive oxygen species (ROS), such as superoxide anion (O 2 ⅐Ϫ ) and hydrogen peroxide (O 2 Ϫ ) with age. 6, 7 The simultaneous production of NO and O 2 ⅐Ϫ favors synthesis of the cytotoxic reaction product peroxynitrite anion (ONOO Ϫ ). 8 Enhanced production of ONOO Ϫ reduces the availability of NO and causes weaker endothelium-dependent vasodilation and a drop in antiinflammatory and antithrombotic protection by NO, leading to more endothelium-platelet contacts. 9 ONOO Ϫ triggers tyrosine nitration in proteins, modifying intracellular protein function. 10 ROS also upregulate nuclear factor B in circulating leukocytes, 11 aggravating proinflammatory and prothrombotic tendencies, the latter evidenced by upregulated tissue factor expression in endothelial cells. 12 Oxidative endothelial cell damage may thus further increase thrombogenicity in the elderly by enhancing platelet activation, as a result of vascular deficiency.
Brain and muscle ARNT-like protein-1 (Bmal1) clock gene-deficient mice with an accelerated aging phenotype are characterized by a prothrombotic tendency in response to experimentally inflicted injury. 13, 14 In addition, these mice display reduced NO bioavailability. 14 We have selected the prematurely aging Bmal1 gene-deficient mouse model to investigate the relationship between vascular aging and thrombogenicity by focusing on risk factors for arterial as well as venous thrombosis. Therefore, in addition to performing time-lapse analysis of primary and secondary hemostatic parameters, we have studied vascular expression profiles, morphology, and function, in young and prematurely aged Bmal1 knockout (KO) mice. We noted the existence of a hypercoagulable state in young mice, progressing toward a prothrombotic state, associated with spontaneous priapism in prematurely aged mice.
Methods

Animal Model
Breeding couples of mice heterozygous for Bmal1 (100% C57BL/6J) were kindly provided by Dr K. Esser (University of Kentucky, Lexington, KY). Male Bmal1-deficient KO mice and wild-type (WT) littermates at the age of 10 weeks (body weight: WT 20.5 to 27 g; KO 17 .0 to 25.0 g) to 30 weeks (body weight: WT 23.0 to 33.0 g; KO 17.3 to 25.0 g) were generated in the animal facility of the Center for Molecular and Vascular Biology (Katholieke Universiteit Leuven, Leuven, Belgium) and genotyped as described elsewhere. 15 All animals were kept in microisolation cages in a temperature-and light-controlled (12-hour night/day cycle) environment and had free access to drinking water and standard chow (KM-04-k12, Muracon, Carfil, Oud-Turnhout, Belgium; 13% kcal as fat, caloric value 10.9 kJ/g) ad libitum. All animal procedures were approved by the Ethical Committee of the Katholieke Universiteit Leuven and performed in accordance with the National Institutes of Health Guide for the Care and Use of Laboratory Animals (1996) .
Procedures
The protocols for the mouse manipulations, blood and plasma assays, isometric tension measurements, in vivo thrombosis and inflammation model, histology and immunohistochemistry and the subsequent microscopy analysis, quantitative real-time polymerase chain reaction, and statistical analysis can be found online in the supplemental materials (available online at http://atvb.ahajournals.org).
Results
Hematologic Changes Associated With Aging of Bmal1
؊/؊ Mice
The white blood cell count and platelet numbers did not change from 10 to 30 weeks in WT mice ( In addition, at 10 weeks, KO mice showed increased white blood cell count, and at 30 weeks, they showed higher red blood cell and platelet counts, as well as a trend toward increased hemoglobin blood levels, compared with WT mice (Table 1) . Eosinophil and lymphocyte numbers were normal in 30-week-old KO mice but not in 10-week-old KO mice ( Table 1 ). The density of VWF-positive megakaryocytes in 30-week-old KO bone marrow was significantly higher than in age-matched control bone marrow, in agreement with the elevated platelet numbers (Figure 1 ). Despite high platelet numbers at 30 weeks in KO mice, platelet aggregation assays revealed a normal platelet response to the agonist ADP (0.5 to 2 mol/L) when tests were executed at comparable platelet numbers (data not shown). Plasma coagulation tests and coagulation factors (accepted risk factors in venous thrombosis) revealed no changes in the activated partial thromboplastin time (aPTT) in WT mouse plasma from 10 to 30 weeks. No consistent changes were found for plasma fibrinogen, FVII, and FVIII levels ( Table  1 ). In contrast, Bmal1 gene deficiency was associated with a prolongation of the aPTT and a shortening of the prothrombin time by 1.6 seconds in 10-week-old mice and 0.8 seconds in 30-week KO mice, compared with their age-matched controls. At 30 weeks, KO mouse plasma FVII was higher than at 10 weeks. Fibrinogen was elevated in KO mouse plasma, independently of age, whereas FVIII seemed transiently elevated at 10 weeks. These findings are compatible with a hypercoagulable state in KO mice, aggravating with aging. Serum levels of the inflammatory factor C-reactive protein were somewhat higher in Bmal1-deficient mice versus WT mice at 10 weeks (KO 171Ϯ20 ng/mL, nϭ8; WT 139Ϯ10 ng/mL, nϭ12; Pϭ0.18) and at 30 weeks (KO 206Ϯ23 ng/mL, nϭ4; WT 143Ϯ11 ng/mL, nϭ14; Pϭ0.06), findings that explain, in part, why aPTT is prolonged, despite shortened prothrombin time values and elevated fibrinogen (see below).
Smooth Muscle and Endothelial Cell Function in Bmal1
The effect of Bmal1 deficiency on aging smooth muscle cell (SMC) and endothelial cell function was tested functionally in thoracic aortic rings isolated from 10-and 30-week-old KO and WT mice. SMC contraction and vasorelaxation were studied in organ chambers in the presence of the nitric oxide synthase (NOS) inhibitors N ⍀ -nitro-L-arginine and N ⍀ -nitro-L-arginine methyl ester. Maximal contractility was not influenced by age or genotype ( Figure 2A , red curves), because aortic rings obtained from both age groups of either genotype developed equal maximum force in response to phenylephrine (PE). At the age of 10 weeks, the sensitivity to PE was equal in both genotypes (pD2 values: WT 7.38Ϯ0.05, KO 7.31Ϯ0.06, nϭ10), but sensitivity to PE was higher in KO rings at 30 weeks (pD2 values: WT 7.17Ϯ0.06, KO 7.57Ϯ0.07, nϭ10, PϽ0.01). Addition of diethylamine NONOate, a donor of exogenous NO, caused complete relaxation in all rings without differences for genotype or age ( Figure 2C ). Morphologically, SMC density was significantly higher in 10-week-old KO mouse aorta segments than in WT segments (WT 3532Ϯ53/m ( Figure 2B ). The effect of NOS inhibition increased with age in WT mice but not in Bmal1-deficient mice, and basal NO release was significantly attenuated by Bmal1 deficiency at the age of 30 weeks.
Subsequently, acetylcholine (ACh) was given to activate eNOS activity by stimulating endothelial muscarinic receptors. In WT aortic rings, ACh caused almost complete relaxation that tended to be more pronounced at 30 weeks. At 10 weeks, Bmal1 deficiency led to a significant reduction of amplitude ( Figure 2D) 
Bmal1 Gene Deficiency Mildly Influences Vascular Pro-and Anticoagulant Pathways During Aging
More detailed investigation of endothelial cell aging showed a 1.5-fold drop of the transcription of the procoagulant vascular tissue factor (initiator of physiological coagulation) with aging in KO aorta extracts (Table 2) . Likewise, mRNA for VWF (a risk factor for arterial thrombosis) appeared to be produced to a lesser degree (1. 
Vascular Inflammatory Changes in Bmal1 KO Mice
Baseline leukocyte rolling over endothelium was hardly affected by activation with A23187 of the mesenteric endothelium, both when analyzed at 10 and 30 weeks. On average, lower numbers of rolling cells were found on Bmal1 KO than WT mouse endothelium at all ages (46Ϯ7 rolling cells in WT mice versus 14Ϯ2 rolling cells in KO mice, PϽ0.05, when analyzed per 5 subsequent frames; see supplemental materials). These findings confirm the absence of a proinflammatory vascular phenotype in mesenteric blood vessels, even suggesting a reduced inflammatory vigilance on Bmal1 KO endothelium, despite higher numbers of circulating leukocytes and somewhat higher plasma C-reactive protein levels in young KO mice (Table 1) .
Increased Arterial and Venous Thrombotic Risk in Bmal1 KO Mice
In view of the existence of an age-dependent plasma hypercoagulable state, reduced NO bioavailability, modified anticoagulant properties in KO mice, and elevated platelet numbers (a risk factor in arterial thrombosis), we have investigated the arterial and venous thromboembolic risk separately in aging Bmal1-deficient mice via controlled vascular injury-induced thrombosis studies. Arteriolar and venular occlusion times were measured in 10-week-old and 20-to 25-week-old WT and KO mice. The 30-week-old KO mice did not survive anesthesia and could not be analyzed; therefore, thrombosis studies were done in slightly younger animals. Figure 3 illustrates that Bmal1 deficiency shortened arteriolar as well as venular occlusion times convincingly at the age of 10 weeks, compatible with early arterial and venous thrombogenicity in KO mice. In 20-to 25-week-old KO mice, enhanced thrombogenicity was only suggested but not formally demonstrated because of the large experimental variability. In KO mice, spontaneous priapism was noted to increase with age, from 0% at 10 weeks (nϭ38) to 8% at 20 to 25 weeks (nϭ38) and 60% at 25 to 30 weeks (nϭ30; PϽ0.0001 versus 20 to 25 weeks). Priapism was absent in WT controls at all ages (nϭ22). Histological examination of KO and WT penile sections (nϭ3) confirmed numerous thrombi in the venous sinus of KO sections (Figure 4b and 4c) but not in WT sections (Figure 4a and 4h) . Thrombosis was evident from the near occlusive VWF-positive thrombi, identified via their location over the entire VWF-positive endothelium in the venous sinus of a KO mouse (Figure 4d) , as from the occlusive thrombus, shown at larger magnification in Figure  4e . Further investigation of the composition of the thrombus via Martius scarlet blue staining (Figure 4f ) revealed thrombi, containing both platelets (purple) and fibrin (red). In addition, fibrin-rich laminar thrombus formation was seen extensively lining the endothelium (Figure 4g ). Surprisingly few inflammatory granulocytes were present in the venous thrombi.
Discussion
According to the triad of Virchow, the increased risk for (arterial and) venous thrombosis during aging can be attributed to age-induced changes in structure and function of the vessel wall, to age-associated alterations in blood flow, and to a shift toward a hypercoagulable state. 1 However, the functional relationships between aging endothelium and enhanced risk, especially for venous thromboembolism, are not fully understood. Because there is increasing evidence that arterial and venous thrombosis share many risk factors, 16 we performed a detailed analysis of arterial and venous thrombogenicity and of their classical risk factors, in association with functional vascular changes in 10-and 30-week-old Bmal1 KO and WT mice, to assess the role of the aging vasculature in thrombogenicity evolution.
Hematologic Changes Associated With Aging of KO Mice
Kondratov et al found more than a 2-fold rise in the percentage of monocytes and neutrophils in aged KO mice. 17 We found a modest neutrophil elevation but did not notice any change in monocyte numbers, but our KO mice had higher numbers of functional platelets at 30 weeks compared with WT mice, in accordance with more VWF-positive megakaryocytes in the bone marrow. This finding is at variance with results by Somanath et al, 18 who did not find platelet changes. These differences may relate to more trivial factors, such as different housing environment, a differential night-day regimen, or the blood isolation procedure. As Bmal1 is a clock gene, exposing KO mice to 2 weeks of constant darkness up to the time of analysis may influence the rhythmicity of several biological parameters.
Aging men develop mild anemia 19 ; in the present study, we found that both erythrocytes and platelets went up at 30 weeks in Bmal1 KO mice. This suggests hematopoietic effects in the myeloid erythroid precursor lineage. Because increased oxidative stress in Bmal1-deficient mice causes premature aging of several (but not all) organs, 17, 20 upregulated ROS with age may be responsible for enhanced megakaryopoiesis and erythropoiesis in the bone marrow numbers of aging KO mice, as has been suggested by O'Brien et al 21 for megakaryocyte maturation.
So far, secondary hemostasis has not been investigated in Bmal1 KO mice. We found that Bmal1 gene deficiency triggers a hypercoagulable state at 10 weeks, evidenced by a shortened prothrombin time and elevated plasma fibrinogen levels (PϽ0.05). In addition, this state worsened with age because of further rising FVII levels (a risk factor for venous thrombosis) at 30 weeks (PϽ0.05). The shortened prothrombin time in KO mice can be explained by increased fibrinogen and FVII levels. In contrast, the prolonged aPTT may result from interference of phospholipid binding inflammatory factors, such as C-reactive protein, measured in the present study and found to be elevated, or serum amyloid protein, which is claimed to be a more important acute phase protein in the mouse. 22 Also, in recent mouse studies, similar apparently conflicting aPTT prolongations have been reported. 23 
Smooth Muscle and Endothelial Cell Function in Bmal1
Aging of arterial vessels is accompanied by a drop in SMC proliferation and reduced contractile responses to vasoactive agents. 24 Endothelial dysfunction or a reduction in NOmediated vasodilation is elicited as a consequence of increases in ROS levels. 9 Anea et al already showed that Bmal1 deficiency attenuates concentration-dependent responses to the vasodilator ACh but that relaxant responses to the endothelium-independent NO donor sodium nitroprusside are similar between 10-week-old KO and WT mice. 14 We have expanded this observation by investigating the contractility of aortic SMCs and the basal and stimulated (endotheliumdependent and -independent) NO production in these mice as a function of age. We observed that Bmal1 deficiency was not accompanied by defects of the contractile function of aortic SMCs, as indicated by (1) normal contractile responses to the ␣ 1 -adrenoceptor agonist PE when eNOS activity was blocked by high concentrations of N ⍀ -nitro-L-arginine/N ⍀ -nitro-Larginine methyl ester, and (2) normal responsiveness to exogenous NO released by the NO donor diethylamine NONOate. However, endothelium-dependent vasomotor responses differed for KO mice. Both basal NO release, assessed by the rise of PE contraction induced by the NOS inhibitors N ⍀ -nitro-L-arginine and N ⍀ -nitro-L-arginine methyl ester, and ACh-muscarinic receptor-induced, endothelium-dependent relaxations were suppressed in aortic rings of Bmal1-deficient mice, particularly at 30 weeks. These defects in endothelial function are not attributed to alterations in eNOS mRNA levels or to mRNA expression or activity of enzymes involved in generation (NADPH oxidase 4, xanthine dehydrogenase) or degradation (catalase, superoxide dismutase 1, glutathione peroxidase 1) of ROS (data not shown). The defect in basal NO production is possibly linked to a posttranscriptional level of regulation of eNOS activity. Anea et al 14 attributed the reduction in ACh-mediated relaxation in 10-to 15-week-old KO mice to a blunted Akt signaling in remodeled arteries. The serine-threonine kinase Akt is involved in cellular survival, stimulates NO production by phosphorylating eNOS on serine residue 1177, and thereby influences vascular function. 25 Therefore, a reduction in Akt signaling results in less phosphorylation of eNOS on Ser1177, a lower NO release, and endothelial dysfunction.
Bmal1 Gene Deficiency Mildly Influences Vascular Pro-and Anticoagulant Pathways During Aging
Endothelial dysfunction can cause a shift toward a procoagulant, proinflammatory, and prothrombotic state favoring thrombotic occlusion. At the gene transcription level, we noticed that the aged arterial endothelium of Bmal1 KO mice became less anticoagulant, because the transcription of the anticoagulant genes TM and endothelial protein C receptor dropped significantly. At the protein level, we observed trends toward an increase of aorta VWF and a drop in aorta TM expression with age in Bmal1 KO mice, tilting the hemostatic balance toward elevated vessel wall-dependent thrombogenicity. Plasma VWF antigen levels, however, were not influenced by age in these mice. The small reduction in TM expression with age in KO animals can be multifactorial: (1) TM is a Clock-Bmal2-controlled gene, the expression of which could be attenuated by age as for Bmal1, Period 1, and Period 2 in vascular endothelial cells 26, 27 ; and (2) Bmal1-deficient endothelium may be exposed to disturbed shear stress in less elastic arteries, resulting in decreases in TM mRNA, as suggested by Malek et al. 28 
Vascular Inflammatory Changes in Bmal1 KO Mice
Plasma fibrinogen and the neutrophil and platelet counts were increased in 30-week-old Bmal1 KO mice compared with WT mice, at first suggestive of a systemic inflammatory phenotype. However, despite lower basal NO production in aortic segments, the endothelium of KO mice did not manifest a proinflammatory state, as fewer leukocytes were found rolling on the (A23187-activated) endothelium of arterioles and venules in the mesenteric circulation of these mice. Therefore, Bmal1 deficiency may not only influence the vascular expression of adhesion molecules but also affect granulocyte function itself and cause a defective inflammatory vigilance, which would also explain the poor thrombus inflammation found in priapism.
Increased Arterial and Venous Thrombotic Risk in Bmal1 KO Mice
Substantially shortened occlusion times were found on FeCl 3 challenge in 10-week-old KO mice, both in arterioles and in venules. Because of the progressive rise with age of procoagulant FVII, an attenuated anticoagulant defense system, and weaker NO synthesis, combined with a doubling of the platelet counts at 30 weeks, we expected to see an aggravation of the prothrombotic state and a further decline of the arterial and venous occlusion times in KO versus WT animals following FeCl 3 injury. This could not be confirmed experimentally, but old KO males spontaneously develop priapism, illustrative of the progressive deterioration of the prothrombotic state. Priapism, the development of thrombosis in the penile blood vessels, leading to erectile dysfunction, depends on both the occurrence of prothrombotic risk factors and vascular dysfunction, especially a deregulation of the NO pathway, 29 both present in 30-week-old Bmal1-deficient mice. Histological analysis of Bmal1 KO penile sections demonstrated the presence of platelet and fibrin-rich thrombi in the venous sinus without significant infiltration of inflammatory cells, ie, linking priapism to thrombosis and illustrating how primary and secondary hemostatic risk factors cooperate to cause thrombosis in the penile venous sinus. Priapism has also been associated with increased oxidative stress. 30 Indeed, whereas young Bmal1-deficient mice do show increased ROS levels in several organs, 17 with increasing age, ROS levels in spleen and kidney further increase in Bmal1 KO mice but not in WT mice. Thus, the lack of Bmal1 induces an increase in ROS production, causing a substantial reduction in the average life span of these mice. Because we did not notice changes in the mRNA of pro-and antioxidant genes and in the level of 3-nitrotyrosine-containing proteins in Bmal1 KO versus WT arteries (independent of age), it is not certain that the endothelial dysfunction in the penile blood vessels, implicated in thrombus formation and priapism, is caused by enhanced oxidative stress. However, in view of the reduced NO production in Bmal1 KO mice, the involvement of ROS cannot be excluded.
In conclusion, the present model of premature aging spontaneously develops a hypercoagulable state, characterized by high plasma fibrinogen, FVIII, and FVII levels. However, because of additional age-induced circulatory changes, such as high platelet numbers and vascular changes, resulting from attenuated NO and anticoagulant factor synthesis, the arterial and venous thrombogenicity in aged Bmal1 KO mice is severely upregulated, culminating in obstructive thrombus formation in penile venus sinuses and priapism. Hence, rapidly aging Bmal1 KO mice represent an in vivo model of spontaneous and accelerated thrombogenicity, which may be applicable in various intervention studies.
